We speculate that studying the synergistic interactions among such inflammatory triggers for CXCL10 induction/upregulation in major immune effectors would be another interesting scenario, given the emerging pathophysiological significance of these inflammatory proteins in metabolic disorders. This evidence concerns the gene CXCL10 and Other metabolic disease.